Professor Mutocheluh's research group focuses on translational research related to microbial pathogens and immunity to microbial diseases, with particular interest in human oncogenic viruses, mycotoxins, anti-viral & anti-cancer agents. The group's current projects include but not limited to the following: (1) Understanding the anti-viral and anti-cancer properties of cryptolepis sanguinolenta; (2) Transforming chronic hepatitis B virus and HIV treatment by developing novel targeted immunotherapy based on a fundamental understanding of the virus immunobiology and (3) identifying small molecules of herbal origin for antiviral and anti-cancer therapy. He's involved in capacity building and mentoring the next generation of african scientists in the area of virology and immunology.